Rutgers scientists unveiled novel cancer cell tech. But the real story is the coming biotech consolidation and the war on drug patents.
Lupin's deal with TTP plc UK isn't just about better inhalers; it’s a desperate play in the high-stakes **pharmaceutical technology** sector.
New breakthroughs in synthetic spider silk are exciting, but the 'unbreakable' hype hides massive production roadblocks and vested interests.
The NIDHC Summit touted breakthroughs, but the real story in **technology** and **innovation** is who controls the pipeline.
Forget solar panels. This new tiny power module could rewrite energy infrastructure. We analyze the hidden winners in this power revolution.
Forget the hype. Deep analysis of CRISPR-based Cellgorithm technology reveals the hidden power struggle and true timeline for this cell programming revolution.
The Netherlands is lifting its ban on surplus embryo research. This isn't just science news; it’s a seismic shift in bioethics and the future of human enhancement.
A quiet Frederick company is set to unveil new bio technology. But who *really* stands to gain from this biotech revolution?